Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation.
Animals
CCAAT-Enhancer-Binding Proteins
/ deficiency
Cell Cycle Proteins
/ deficiency
Ceruletide
/ toxicity
Coculture Techniques
Connective Tissue Growth Factor
/ antagonists & inhibitors
Disease Models, Animal
Down-Regulation
Hippo Signaling Pathway
Humans
Macrophages
/ metabolism
Mice
Mice, Inbred C57BL
Mice, Knockout
PTEN Phosphohydrolase
/ deficiency
Pancreatic Stellate Cells
/ metabolism
Pancreatitis, Chronic
/ etiology
Phosphatidylinositol 3-Kinases
/ metabolism
Protein Serine-Threonine Kinases
/ metabolism
Signal Transduction
Up-Regulation
Gastroenterology
Molecular pathology
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
received:
18
08
2020
accepted:
11
05
2021
pubmed:
26
5
2021
medline:
14
10
2021
entrez:
25
5
2021
Statut:
ppublish
Résumé
The role of PI3K and Hippo signaling in chronic pancreatitis (CP) pathogenesis is unclear. Therefore, we assessed the involvement of these pathways in CP by examining the PI3K and Hippo signaling components PTEN and SAV1, respectively. We observed significant decreases in pancreatic PTEN and SAV1 levels in 2 murine CP models: repeated cerulein injection and pancreatic ductal ligation. Additionally, pancreas-specific deletion of Pten and Sav1 (DKO) induced CP in mice. Pancreatic connective tissue growth factor (CTGF) was markedly upregulated in both CP models and DKO mice, and pancreatic CCAAT/enhancer-binding protein-α (CEBPA) expression was downregulated in the CP models. Interestingly, in pancreatic acinar cells (PACs), CEBPA knockdown reduced PTEN and SAV1 and increased CTGF levels in vitro. Furthermore, CEBPA knockdown in PACs induced acinar-to-ductal metaplasia and activation of cocultured macrophages and pancreatic stellate cells. These results were mitigated by CTGF inhibition. CP in DKO mice was also ameliorated by Ctgf gene deletion, and cerulein-induced CP was alleviated by antibody-mediated CTGF neutralization. Finally, we observed significantly decreased PTEN, SAV1, and CEBPA and increased CTGF levels in human CP tissues compared with nonpancreatitis tissues. Taken together, our results indicate that dysregulation of PI3K and Hippo signaling induces CP via CTGF upregulation.
Identifiants
pubmed: 34032634
pii: 143414
doi: 10.1172/JCI143414
pmc: PMC8245178
doi:
pii:
Substances chimiques
CCAAT-Enhancer-Binding Proteins
0
CCN2 protein, human
0
CCN2 protein, mouse
0
CEBPA protein, human
0
CEBPA protein, mouse
0
Cell Cycle Proteins
0
SAV1 protein, human
0
Sav1 protein, mouse
0
Connective Tissue Growth Factor
139568-91-5
Ceruletide
888Y08971B
Protein Serine-Threonine Kinases
EC 2.7.11.1
PTEN Phosphohydrolase
EC 3.1.3.67
PTEN protein, human
EC 3.1.3.67
Pten protein, mouse
EC 3.1.3.67
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Cancer Discov. 2011 Jul;1(2):158-69
pubmed: 21984975
Tumour Biol. 2016 Oct 17;:
pubmed: 27747589
Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):442-7
pubmed: 20661135
Genes Dev. 2004 Aug 15;18(16):1926-45
pubmed: 15314020
Cell Commun Signal. 2019 May 17;17(1):45
pubmed: 31101053
J Biol Chem. 2016 Jul 29;291(31):16390-403
pubmed: 27129246
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20311-6
pubmed: 21059933
Cancer Res. 2018 Sep 1;78(17):4902-4914
pubmed: 29967264
Oncotarget. 2017 May 18;8(38):62953-62961
pubmed: 28968962
Anticancer Res. 2019 Jul;39(7):3317-3321
pubmed: 31262852
Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10417-E10426
pubmed: 30327349
Gastroenterology. 2020 May;158(6):1626-1641.e8
pubmed: 31930989
J Pineal Res. 2009 Oct;47(3):221-7
pubmed: 19663997
Nat Commun. 2015 May 18;6:7158
pubmed: 25981357
J Cell Physiol. 2019 Aug;234(10):18131-18145
pubmed: 30891776
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D108-10
pubmed: 16381825
Int J Cancer. 2009 Feb 15;124(4):827-33
pubmed: 19035457
Nat Cell Biol. 2012 Dec;14(12):1322-9
pubmed: 23143395
Hepatol Res. 2003 May;26(1):1-9
pubmed: 12787797
Mol Endocrinol. 2004 Aug;18(8):1975-87
pubmed: 15155787
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1437-42
pubmed: 20080689
Dig Dis Sci. 2017 Jul;62(7):1702-1712
pubmed: 28501969
Cell. 2008 Jan 25;132(2):197-207
pubmed: 18243096
Ann Surg. 1999 Jul;230(1):63-71
pubmed: 10400038
Mod Pathol. 2007 Feb;20 Suppl 1:S113-31
pubmed: 17486047
J Clin Invest. 2011 Aug;121(8):3343-56
pubmed: 21747166
Sci Rep. 2019 May 8;9(1):7072
pubmed: 31068602
Sci Rep. 2015 Nov 16;5:16759
pubmed: 26567630
Mol Cancer Res. 2011 Oct;9(10):1395-405
pubmed: 21813505
Physiol Rev. 2014 Oct;94(4):1287-312
pubmed: 25287865
Immunology. 2014 Apr;141(4):564-76
pubmed: 24754049
N Engl J Med. 1993 May 20;328(20):1433-7
pubmed: 8479461
Mol Cancer Res. 2018 Jun;16(6):1046-1058
pubmed: 29545474
Liver Int. 2008 Sep;28(8):1065-79
pubmed: 18783549
Cytokine Growth Factor Rev. 2013 Feb;24(1):59-68
pubmed: 22884427
J Mol Cell Cardiol. 2018 Aug;121:205-211
pubmed: 30040954
J Exp Clin Cancer Res. 2018 Aug 22;37(1):198
pubmed: 30134988
Cancer Lett. 2014 Apr 10;345(2):203-9
pubmed: 23981573
Sci Rep. 2017 Feb 13;7:42114
pubmed: 28191821
PLoS Biol. 2019 Sep 12;17(9):e3000418
pubmed: 31513574
Nat Cell Biol. 2011 Aug 01;13(8):877-83
pubmed: 21808241
J Clin Oncol. 2009 Feb 1;27(4):619-28
pubmed: 19075268
Gastroenterology. 2016 Sep;151(3):526-39
pubmed: 27215660
J Cell Commun Signal. 2016 Jun;10(2):121-7
pubmed: 27098435
J Biol Chem. 1996 Oct 4;271(40):24753-60
pubmed: 8798745
Gastroenterology. 2010 Jun;138(7):2487-98, 2498.e1-7
pubmed: 20206174
Cancer Res. 2010 Sep 15;70(18):7114-24
pubmed: 20807812
Am J Pathol. 2007 Jul;171(1):263-73
pubmed: 17591971